Retatrutide
30mg
FormulaC221H342N46O68
Triple-agonist peptide studied at GLP-1, GIP and glucagon receptors.
View Retatrutide 30mg
Research Module
Save 20%Metabolic Flow
Incretin-receptor signaling studied alongside mitochondrial and NAD+-dependent energy pathways.
- Individual value
- —
- Savings (20%)
- —
- Module price
- —
Priced from the current price of each vial. Research use only.
01In this module
Three compounds
MOTS-c
10mg
FormulaC101H152N28O22S2
Mitochondria-derived peptide studied in metabolic signaling.
View MOTS-c 10mg
NAD+
500mg
FormulaC21H27N7O14P2
Redox cofactor central to cellular energy metabolism.
View NAD+ 500mg02Research focus
Why these three?
Retatrutide is studied at three metabolic receptors. MOTS-c is a mitochondria-derived peptide examined in metabolic signaling. NAD+ is the cofactor these energy pathways run on.
Metabolic Flow
——Save 20%
Documentation